Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gordon Ringold currently holds 25,000 shares of Alexza Pharmaceuticals Inc. (ALXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gordon Ringold has been a net seller of ALXA stock. They have purchased $556.8K and sold $3.9M worth of shares.
Gordon Ringold's most recent insider trade was on Aug 23, 2023, when they sold 10,000 shares at $0.00 per share.
Gordon Ringold serves as Executive at Alexza Pharmaceuticals Inc. (ALXA). They have executed 319 insider transactions totaling $4.5M over their tenure at the company.
Gordon Ringold holds the position of Executive at Alexza Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gordon Ringold has shown a selling trading pattern, with $556.8K in total purchases and $3.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gordon Ringold was on Jun 10, 2015, when they purchased $151.9K worth of ARDX shares. This transaction involved 10,000 shares at $15.19 per share.
Gordon Ringold currently owns 25,000 shares of Alexza Pharmaceuticals Inc. (ALXA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gordon Ringold's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gordon Ringold has 319 Form 4 filings on record as an insider at Alexza Pharmaceuticals Inc..
Set alerts for Gordon Ringold and 40,000+ other insiders.